LINDSEY STEIGERWALD: Open Payments
NPI 1740048768 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $448
Food & beverage: $336Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $153 |
| Corium, LLC | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: CAPLYTA, Azstarys, AUSTEDO XR, REXULTI, UZEDY, VRAYLAR, SPRAVATO.
Industry payments across CO — which companies pay providers there.
